OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real World Experience with Regdanvimab Treatment of Mild-to-Moderate Coronavirus Disease-19 in a COVID-19 Designated Hospital of Korea
Sun In Hong, Byung-Han Ryu, Kyung‐Wook Hong, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 1, pp. 114-114
Open Access | Times Cited: 13
Sun In Hong, Byung-Han Ryu, Kyung‐Wook Hong, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 1, pp. 114-114
Open Access | Times Cited: 13
Showing 13 citing articles:
COVID-19: An Update on the Latest Therapeutic Agents
Ke-Yan Loo, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Ke-Yan Loo, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
COVID-19 Outbreak in Daegu City, Korea and Response to COVID-19: How Have We Dealt and What Are the Lessons?
Shin‐Woo Kim
Journal of Korean Medical Science (2022) Vol. 37, Iss. 50
Open Access | Times Cited: 13
Shin‐Woo Kim
Journal of Korean Medical Science (2022) Vol. 37, Iss. 50
Open Access | Times Cited: 13
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
Mingyang Yang, Toni Li, Lihai Jiang, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. e122-e124
Open Access | Times Cited: 8
Mingyang Yang, Toni Li, Lihai Jiang, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. e122-e124
Open Access | Times Cited: 8
Nirmatrelvir/Ritonavir Prescription Rate and Outcomes in Coronavirus Disease 2019: A Single Center Study
Jin Ju Park, Jacob Lee, Yu Bin Seo, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 4, pp. 757-757
Open Access | Times Cited: 8
Jin Ju Park, Jacob Lee, Yu Bin Seo, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 4, pp. 757-757
Open Access | Times Cited: 8
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
Jaehyun Jeon, Bum Sik Chin
Journal of Korean Medical Science (2022) Vol. 37, Iss. 48
Open Access | Times Cited: 7
Jaehyun Jeon, Bum Sik Chin
Journal of Korean Medical Science (2022) Vol. 37, Iss. 48
Open Access | Times Cited: 7
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study
Susin Park, Nam Kyung Je, Dong Wan Kim, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Susin Park, Nam Kyung Je, Dong Wan Kim, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
Yee Gyung Kwak, Je Eun Song, Jieun Kang, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 4, pp. 781-781
Open Access | Times Cited: 5
Yee Gyung Kwak, Je Eun Song, Jieun Kang, et al.
Infection and Chemotherapy (2022) Vol. 54, Iss. 4, pp. 781-781
Open Access | Times Cited: 5
Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study
Hyeong-Jun Noh, Jin Hwa Song, Sin Young Ham, et al.
Medicine (2023) Vol. 102, Iss. 45, pp. e35987-e35987
Open Access | Times Cited: 2
Hyeong-Jun Noh, Jin Hwa Song, Sin Young Ham, et al.
Medicine (2023) Vol. 102, Iss. 45, pp. e35987-e35987
Open Access | Times Cited: 2
CLINICAL EFFECTIVENESS OF REGDANVIMAB IN THE TREATMENT OF PATIENTS WITH COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
Morteza Zaboli Mahdiabadi, Zahra Abbasi Dolatabadi, Fatemeh Nemati Dopolani, et al.
Studies in Medical Sciences (2023) Vol. 33, Iss. 11, pp. 786-795
Open Access | Times Cited: 1
Morteza Zaboli Mahdiabadi, Zahra Abbasi Dolatabadi, Fatemeh Nemati Dopolani, et al.
Studies in Medical Sciences (2023) Vol. 33, Iss. 11, pp. 786-795
Open Access | Times Cited: 1
Efficacy and safety of regdanvimab in patients with mild to moderate COVID‐19: A rapid review and meta‐analysis
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Regdanvimab Treatment of COVID-19
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Infection and Chemotherapy (2022) Vol. 54, Iss. 3, pp. 547-547
Open Access
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Infection and Chemotherapy (2022) Vol. 54, Iss. 3, pp. 547-547
Open Access
Effectiveness of Regdanvimab and Remdesivir in Patients with COVID-19 at a Single Hospital
Sunmo Kim, Hwee-Soo Jeong, Jisun Lim, et al.
Korean Journal of Family Practice (2022) Vol. 12, Iss. 5, pp. 340-345
Open Access
Sunmo Kim, Hwee-Soo Jeong, Jisun Lim, et al.
Korean Journal of Family Practice (2022) Vol. 12, Iss. 5, pp. 340-345
Open Access
